Odyssey Therapeutics, Inc.NASDAQ: ODTX

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

· Issued by Odyssey Therapeutics, Inc. via GlobeNewswire

Summary by 6ix AI

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company developing medicines for autoimmune and inflammatory diseases, said members of its management team will take part in fireside chats at three investor conferences in New York, NY, in September 2026.

Key details

  • 2026 Cantor Global Healthcare Conference, September 9-11, 2026: fireside chat on September 9 at 8:35AM ET.
  • Morgan Stanley 24th Annual Global Healthcare Conference, September 14-16, 2026: fireside chat on September 14 at 10:45AM ET.
  • H.C. Wainwright 28th Annual Global Investment Conference, September 14-16, 2026: fireside chat on September 15 at 1:00PM ET.
  • Live webcasts will be offered where available on Odyssey's investor website, with replays archived for 60 days.

6ix AI wrote this summary from the release below and checked it against the release.

BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) ("Odyssey" or the "Company"), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September:

  • 2026 Cantor Global Healthcare Conference
    Conference Dates: September 9-11, 2026
    Location: New York, NY
    Fireside Chat: September 9th at 8:35AM ET

  • Morgan Stanley 24th Annual Global Healthcare Conference
    Conference Dates: September 14-16, 2026
    Location: New York, NY
    Fireside Chat: September 14th at 10:45AM ET

  • H.C. Wainwright 28th Annual Global Investment Conference
    Conference Dates: September 14-16, 2026
    Location: New York, NY
    Fireside Chat: September 15th at 1:00PM ET

Where available, live webcasts will be available under "News and Events" in the Investors section of the Company's website at www.odysseytx.com. Replays of the webcasts will be made available on the Events page of Odyssey's investor website and archived for 60 days.

About Odyssey Therapeutics

Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of internally discovered and developed medicines with its first program advancing through multiple clinical milestones. Odyssey's portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the Company believes have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.

For more information, please visit https://odysseytx.com/ and follow Odyssey on LinkedIn or X.

Contacts

Investor Relations
Collin Todd
SVP, Strategy and Business Development
[email protected]

Odyssey Therapeutics, Inc. on 6ix

Earlier from Odyssey Therapeutics

Later from Odyssey Therapeutics

All Odyssey Therapeutics news releases